Clinical trials
Phase 1 Overweight trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 13 |
| 2025 | 26 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 18 |
| Not yet recruiting | 10 |
| Active, not recruiting | 5 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Shengdi Pharmaceutical Co., Ltd. | 7 |
| Beijing QL Biopharmaceutical Co.,Ltd | 5 |
| Shanghai Minwei Biotechnology Co., Ltd | 5 |
| Vincentage Pharma Co., Ltd | 5 |
| BrightGene Bio-Medical Technology Co., Ltd. | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 4 |
| Innovent Biologics (Suzhou) Co. Ltd. | 4 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 3 |
| Novo Nordisk A/S | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 74 |
| Obesity | 69 |
| Diabetes Mellitus, Type 2 | 11 |
| Diabetes Mellitus | 2 |
| Fatty Liver | 1 |
| Hyperlipidemias | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.